Dr. Stefania Bonaccorso attained her medical education and psychiatry degree at the University of Rome “La Sapienza”, Italy.
Over the years, she has acquired immense clinical and research experience, both in Europe and U.S.
She started as a clinical fellow at the Centre Hopitalier Saint’ Anne, Paris, following graduation in 1996. She continued as a research fellow at the University of Antwerp in 1997, where she commenced her Ph.D., studying the interaction between immune system and depression. She completed the Ph.D. in Maastricht in 2005, with a thesis about mood disorder and interferon-alpha in patients with hepatitis C with the title, “Cytokines: a neurochemical hypothesis”.
Dr. Bonaccorso also has vast experience in pre-clinical and clinical psychopharmacology, with studies on animals and humans conducted in United States at the University of Boulder, Colorado, with Prof. S. Maier in 1999; and in 2000 and 2005 at the Vanderbilt University, Tennessee, with Prof. Herb Meltzer.
At the present moment, she is appointed as a Clinical Lecturer at the Institute of Psychiatry, Maudsley Hospital at King’s College, where she is involved in a study regarding intervention in patients with first episode psychosis taking atypical antipsychotics and developing metabolic abnormalities. The study is directed by Prof, Robin Murray, Head of the Division of Psychological Medicine and Psychiatry. She also works at the National Psychosis Unit where she takes care of severe mentally ill patients affected by psychosis.
Medical School: University of Rome, “La Sapienza”, Italy.
Hospital Appointments: King’s College.
Main Interests: Psychosis, depression, affective disorders, interferon alpha, hepatitis C, bipolar illness, fibromyalgia, personality disorders, metabolic syndrome, atypical antipsychotics.
Spoken Languages: English, Italian, and French.